Inês Figueiredo-Nunes

Inês Figueiredo-Nunes

Auto-generated profile, based on publicly available information

Inês Figueiredo-Nunes

Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Host Pathogen Interact Unit, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2022 in Virology
Verified
Journal Article
Open access
IFInês Figueiredo-Nunes
Inês Figueiredo-Nunes
TTTrigueiro-Louro Trigueiro-Louro
Trigueiro-Louro Trigueiro-Louro
HAHelena Rebelo De Andrade
Helena Rebelo De Andrade
Influenza and COVID-19 are infectious respiratory diseases that represent a major concern to public health with social and economic impact worldwide, for which the available therapeutic options are not satisfactory. The RdRp has a central role in viral replication and thus represents a major target for the development of antiviral approaches. In this study, we focused on Influenza A virus PB1 polymerase protein and the betacoronaviruses nsp12 polymerase protein, considering their functional and structural similarities. We have performed conservation and druggability analysis to map conserved druggable regions, that may have functional or structural importance in these proteins. We disclosed the most promising and new targeting regions for the discovery of new potential polymerase inhibitors. Conserved druggable regions of putative interaction with favipiravir and molnupiravir were also mapped. We have also compared and integrated the current findings with previous research.